Comment
. 2005 Feb 21;182(4):198; author reply 199.
doi: 10.5694/j.1326-5377.2005.tb06656.x.
Possible genetic predisposition to cardiac effects
- PMID: 15720180
- DOI: 10.5694/j.1326-5377.2005.tb06656.x
Item in Clipboard
Comment
Possible genetic predisposition to cardiac effects
Med J Aust.
.
No abstract available
Comment on
-
Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions: we need processes in place to follow up suspicions about serious adverse events.Med J Aust. 2004 Nov 15;181(10):524-5. doi: 10.5694/j.1326-5377.2004.tb06433.x. Med J Aust. 2004. PMID: 15540956 No abstract available.
Similar articles
-
Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk.Atherosclerosis. 2012 Sep;224(1):129-35. doi: 10.1016/j.atherosclerosis.2012.07.001. Epub 2012 Jul 13. Atherosclerosis. 2012. PMID: 22835628
-
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease.Cardiovasc Res. 2010 May 1;86(2):243-53. doi: 10.1093/cvr/cvq016. Epub 2010 Jan 21. Cardiovasc Res. 2010. PMID: 20093252 Review.
-
Depression, inflammation, and cardiovascular disease: is 5-lipoxygenase the missing link?J Am Coll Cardiol. 2008 May 20;51(20):1990-1; author reply 1991. doi: 10.1016/j.jacc.2007.12.055. J Am Coll Cardiol. 2008. PMID: 18482671 No abstract available.
-
Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation.Science. 2004 Feb 13;303(5660):941. doi: 10.1126/science.303.5660.941a. Science. 2004. PMID: 14963296 No abstract available.
-
Mechanisms of cyclooxygenase-2 inhibition and cardiovascular side effects: the plot thickens.Cancer Prev Res (Phila). 2009 Apr;2(4):288-90. doi: 10.1158/1940-6207.CAPR-09-0033. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336721 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
